Call Today: 800-889-3898
Submit your Raptiva claim details for a free, no obligation case review
Get Started:
A Raptiva recall was announced April 8, 2009. The voluntary recall, issued by the manufacturer of the Raptiva medication, Genentech, includes all lots of the Psoriasis drug. According to a statement issued by the U.S. Food and Drug Administration (FDA), Genentech has initiated a complete withdrawal of the drug from the U.S. market, and by June 2009, Raptiva will no longer be available in the U.S.
The Raptiva recall was based on the risk of users developing a serious, fatal brain infection, progressive multifocal leukoencephalopathy (PML). PML is an irreversible condition in which the white matter in the brain begins to swell. Over time, affected individuals begin to suffer traumatic injuries and, in most cases, death.
PML has been linked to long-term Raptiva (generic name: efalizumab) use. If you or someone you love has been prescribed Raptiva to treat Psoriasis and experience any of the following symptoms, you should seek medical attention immediately:
Currently there is no cure for Raptiva PML. Affected individuals generally suffer weeks or months of trauma and disability before death.
In addition to progressive multifocal leukoencephalopathy, Raptiva has also been linked to other serious, potentially life-threatening infections, including:
Since it was approved by the FDA in 2003, the Raptiva drug has been a topic of concern among healthcare professionals as it has been linked to serious, fatal side effects. The FDA has been aware of the potential risks for some time and just last year updated the warning label on Raptiva’s packaging to include warnings of the PML risk. And, on Feb. 19, 2009, the FDA issued a Public Health Advisory informing patients of the risk of PML. The advisory followed confirmation of three deaths from PML, all of whom were being treated with Raptiva.
The Raptiva recall strongly advises patients to stop use of the Psoriasis drug immediately. It also asks prescribers not to administer Raptiva to new patients and to find alternative treatment methods for current users.
Patients who have been injured after taking a Raptiva drug treatment should first meet with a medical professional. After their condition is stabilized, they should consult with an experienced Raptiva attorney who will evaluate their case and fight to recover compensation for their losses.
Experienced Raptiva recall lawyers are knowledgeable about the life-threatening brain infections associated with the drug designed to treat Psoriasis and will be able to help you recover compensation for your losses.
Surviving family members of patients who have died from Raptiva PML or another infection may also be eligible to recover compensation for their losses.
For more information about your legal rights, please contact us today. Our Raptiva attorneys provide free consultations to affected individuals and families and will not ask for payment until a court award or settlement is reached.
The U.S. Food and Drug Administration (FDA) announced a voluntary Raptiva recall, April 8, 2009. The Psoriasis drug’s manufacturer, Genentech, announced the voluntary Raptiva recall and has begun phasing the drug off the U.S. market. R...
Copyright © 2001 - 2010 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.